The week in review
Legislative changes to employee rights, and pharmacists’ scope of practice captured the headlines in the week, before focus shifted to the impact of drug overdoses on Australians The week started …
‘Thank you’: How I saved a patient’s life with naloxone
Pharmacist and owner Amy Ford shares her story for International Overdose Awareness Day I am the owner of Hope Island 7 Day Amcal Chemist and have been a pharmacist and …
Epigenetics and immune health
The immune system serves as the body’s first line of defence. We investigate some of the latest research findings on immune health Our highly complex immune system is regulated by …
Looking into the vaping circus
Vaping, medicinal cannabis and more: a look at the highlights from the upcoming harm minimisation stream at Pharmacy Connect Not since the movement of codeine from an over-the-counter product to …
Ramsay Health Care flags wage concerns
Pharmacy delivers growth for Ramsay Health Care in 2024, but the next 12 months are unlikely to be smooth sailing Private health and pharmacy operator Ramsay Health Care has increased …
Emergence of nitazenes highlights need for Take Home Naloxone
Pharmacies are being urged to stock naloxone to help combat opioid overdose risks Increasing cases of nitazenes being detected in Australia highlights the important role community pharmacies play in providing …
IV manufacturer ‘running flat out:’ Minister
The IV fluid situation is “stabilising,” says health minister Mark Butler, but one expert says Labor’s approach does not fix the underlying issue On Wednesday (28 August), Butler said that …
Barbiturate, alcohol warning…and an arsenic retrospective
Barbiturate poisonings on the rise, a proposal to require scripts for the “so-called tranquilising drugs” and a crackdown on arsenic sales – how pharmacy was changing in the 50s The …
Complete your AJP CPD here
AJP CPD activities published since July this year are no longer hosted on the ACP or GuildEd websites, but don’t panic! You can complete your AJP CPD right here The …
Longer lead time was needed for minimum stock requirements
Stakeholders believe the government should have given pharmaceutical companies an 18 to 24-month window to comply with minimum stock requirements Data from the Review of the Minimum Stockholding Requirements – …
‘An obvious void’ left by NPS MedicineWise closure
No one single organisation or person owns QUM following the demise of NPS MedicineWise, say key stakeholders, with some programs still on hold or under review The Quality Use of …
Priceline sales boost Wesfarmers Health results
Pharmacy business delivers growth for Wesfarmers, with Priceline franchise network continuing its expansion Wesfarmers Health lifted its revenue by almost 6% in the most recent financial year, with strong Priceline …